ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

50
Analysis
Health CareAustralia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
bullishPsc Insurance
31 Jul 2024 12:10

Quiddity Leaderboard ASX Sep 24 Rebal: The Strong Returns of ASX 300 LONG-SHORT Trade Could Continue

If the new shares issued by Westgold (WGX AU) for its acquisition of Karora (KRR CN) is added to its initial share count, Westgold will become the...

Share
bullishZip
19 Jul 2024 05:21

S&P/ASX 100/200 Index Adhoc Rebalance: Potential Replacements for Altium (ALU AU)

Passives will need to trade ZIP and TLX at the close today as part of the ad hoc rebalance triggered by Renesas acquiring Altium. ZIP and TLX have...

Logo
847 Views
Share
bullishSingtel
29 Jun 2024 00:22

Reiterating Japan Overweight -- Add Exposure; Nikkei 225, TOPIX, TOPIX Small All Breaking Out

Reiterating Japan Overweight; $Nikkei 225, $TOPIX, TOPIX Small, $DXJ All Breaking Out with 2+ year RS uptrends intact on Nikkei and TOPIX. Still...

Logo
368 Views
Share
21 Jun 2024 06:00

Tamboran Resources US Offering - Strong Recent Momentum but CDIs Have Been Volatile Since Listing

Tamboran Resources (TBN AU) is looking to raise US$175m from listing its shares in the US. In this note, we talk about the deal dynamics and the...

Logo
502 Views
Share
17 Jun 2024 07:45

ECM Weekly (17th June 2024)-Shift Up, Webtoon, Quantum, Guzman, MaoGeping, Johor Plant, Telix, Atour

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
175 Views
Share
x